Building Engagement Using Financial Incentives Trial - Hypertension
BENEFIT-H
1 other identifier
interventional
50
1 country
2
Brief Summary
The goal of this pilot clinical trial is to determine feasibility and explore whether immediate versus delayed patient financial incentives improve patient engagement with self-monitoring of blood pressure in patients with uncontrolled hypertension at Louisiana federally qualified health centers (FQHCs). The main questions it aims to answer are:
- Do patients randomized to receive financial incentives on a weekly basis during the study (immediate) have better adherence to blood pressure self-monitoring compared to patients randomized to receive financial incentives at the end of the study (delayed)?
- Do patients randomized to immediate financial incentives have better blood pressure control compared to patients randomized to delayed incentives? Participants will:
- attend a baseline visit to measure blood pressure, respond to a baseline survey, and receive remote patient monitoring devices and instructions to take home with them (home blood pressure monitor, wrist-worn sensor to track sleep activity, and associated apps)
- receive a random allocation to one of two groups: control condition (receive cash incentives at the end of the study for measuring blood pressure as instructed) or intervention condition (receive weekly cash incentives throughout the study for measuring blood pressure as instructed)
- use remote patient monitoring devices during a two month study period, receive weekly reports on adherence to blood pressure monitoring, and receive weekly financial incentives (intervention condition only)
- attend one follow-up visit at 2 months to measure their blood pressure, complete a follow-up survey, return the remote patient monitoring devices, and receive financial incentives for blood pressure monitoring (control condition only) Researchers will compare the immediate and delayed incentive groups to see if there are differences in blood pressure monitoring adherence rates and blood pressure control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started May 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2023
CompletedFirst Posted
Study publicly available on registry
January 8, 2024
CompletedStudy Start
First participant enrolled
May 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 11, 2025
CompletedSeptember 17, 2025
September 1, 2025
1.3 years
December 20, 2023
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Between-group difference in weekly adherence to blood pressure monitoring
Weekly adherence to blood pressure monitoring will be defined as the number of days that the participant used the home blood pressure monitor at least once, captured in the blood pressure monitoring app usage data.
8 weeks
Secondary Outcomes (4)
Between-group mean difference in change in systolic blood pressure
8 weeks
Between-group mean difference in change in diastolic blood pressure
8 weeks
Between-group difference in the proportion with blood pressure control (<130/80 mm Hg)
8 weeks
Between-group difference in the proportion with systolic blood pressure control (<130 mm Hg)
8 weeks
Other Outcomes (4)
Number of patient approached for recruitment
3 months
Number of patients assessed for eligibility
3 months
Number of patients enrolled
3 months
- +1 more other outcomes
Study Arms (2)
Immediate Financial Incentives for BP monitoring
EXPERIMENTAL* instructions for participating in a 2-month remote patient monitoring program * home blood pressure monitor and associated smartphone app, which includes a module for logging medication-taking * wrist-worn sensor and associated smartphone app * weekly adherence feedback to home blood pressure monitoring * immediate financial incentives for home blood pressure monitoring distributed weekly
Delayed Financial Incentives for BP monitoring
ACTIVE COMPARATOR* instructions for participating in a 2-month remote patient monitoring program * home blood pressure monitor and associated smartphone app, which includes a module for logging medication-taking * wrist-worn sensor and associated smartphone app * weekly adherence feedback to home blood pressure monitoring * delayed financial incentives for home blood pressure monitoring distributed at the end of the study
Interventions
Participants will be given a home blood pressure machine and instructed to take their blood pressure twice/day (once in the morning and once at night) for the duration of the 2-month study. Blood pressure values will be immediately available in their patient-facing portal accessible via smartphone app, and patients will receive weekly feedback reports on their adherence to the home blood pressure monitoring protocol. Patients' blood pressure values will also be accessible to their clinical care team via an administrator portal, which will alert clinicians of any values above or below pre-specified clinical thresholds.
As part of self-monitoring of hypertension-related factors, the blood pressure monitoring patient-facing app will also prompt patients daily to report whether or not they took their blood pressure medication. in addition, participants will be provided with a wrist-worn sensor and instructed to wear it at night to track their sleep activity. Data on sleep activity will be available to patients through a separate patient-facing app accessible on their smartphone.
Weekly financial incentives for measuring their blood pressure as instructed (up to $25/week: $5/day for up to 5 days/week)
Financial incentives for measuring their blood pressure as instructed in one payment at the end of the study (up to $25/week: $5/day for up to 5 days/week)
Eligibility Criteria
You may qualify if:
- Age ≥40 years
- receive care at a participating FQHC
- taking blood pressure medication
- uncontrolled blood pressure at most recent clinic visit (systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥80 mm Hg)
- ability to understand and speak English
- able to access a smartphone
You may not qualify if:
- currently participating in another clinical trial or research study on blood pressure, medication-taking, or sleep
- unable or unwilling to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CommuniHealth Services
Bastrop, Louisiana, 71220, United States
David Raines Community Health Center
Shreveport, Louisiana, 71107, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie Krousel-Wood, MD, MSPH
Tulane University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2023
First Posted
January 8, 2024
Study Start
May 22, 2024
Primary Completion
September 11, 2025
Study Completion
September 11, 2025
Last Updated
September 17, 2025
Record last verified: 2025-09